European Organisation for Research and Treatment of Cancer - EORTC
11
Radboud University Medical Center
3
University Medical Center Groningen
2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
1
ETOP IBCSG Partners Foundation
1
Gustave Roussy, Cancer Campus, Grand Paris
1
Leiden University Medical Center
1
Maastricht Radiation Oncology
1
Clinical Trials at Arnhems Radiotherapeutisch Instituut
During the past decade, Arnhems Radiotherapeutisch Instituut conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on
average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed
Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy
2001-10-01
Terminated
26
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Arnhems Radiotherapeutisch Instituut" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 11 trials, followed by "Radboud University Medical Center" with 3 trials
sponsored, "University Medical Center Groningen" with 2 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials sponsored and "ETOP IBCSG Partners Foundation"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Arnhems Radiotherapeutisch Instituut"
#1 collaborator was "Dutch Cancer Society" with 5 trials as a collaborator, "Maastro Clinic, The Netherlands" with 2 trials as a collaborator, "Radiotherapiegroep" with 2 trials as a collaborator, "Amsterdam UMC, location VUmc" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were
collaborators in the rest 18 trials.
Clinical Trials Conditions at Arnhems Radiotherapeutisch Instituut
According to Clinical.Site data, the most researched conditions in "Arnhems Radiotherapeutisch Instituut" are
"Lung Cancer" (5 trials), "Breast Cancer" (4 trials), "Prostate Cancer" (3 trials), "Anal Cancer" (1 trials) and "Brain and Central Nervous System Tumors" (1 trials). Many other conditions were trialed in "Arnhems Radiotherapeutisch Instituut" in a lesser frequency.
Clinical Trials Intervention Types at Arnhems Radiotherapeutisch Instituut
Most popular intervention types in "Arnhems Radiotherapeutisch Instituut" are "Radiation" (15 trials), "Drug" (7 trials), "Procedure" (6 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "radiation therapy" (10 trials), "cisplatin" (4 trials), "adjuvant therapy" (3 trials), "conventional surgery" (2 trials) and "gemcitabine hydrochloride" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Arnhems Radiotherapeutisch Instituut
The vast majority of trials in "Arnhems Radiotherapeutisch Instituut" are
13 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Arnhems Radiotherapeutisch Instituut
Currently, there are NaN active trials in "Arnhems Radiotherapeutisch Instituut".
undefined are not yet recruiting,
5 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Arnhems Radiotherapeutisch Instituut,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Arnhems Radiotherapeutisch Instituut, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 4 trials that are defined as “Not Applicable".